Tirzepatide maintains weight loss in adults with obesity, study finds
This is an editorial summary of research originally reported by The Lancet. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Adults who stop taking tirzepatide after weight loss tend to regain the weight, but continuing the drug keeps the weight off and protects heart health. A lower dose of 5 mg might work for some people who can't tolerate higher doses, though results vary by individual. This shows that obesity treatment needs to be ongoing, not just short-term.
Tirzepatide shows promise for keeping weight off long-term, new trial finds
A major clinical trial has tested whether people with obesity can maintain their weight loss after taking tirzepatide, a newer obesity medication. The study, called SURMOUNT-MAINTAIN, tracked adults who had already lost weight on the drug. Researchers wanted to know what happened when people either continued the medication, reduced their dose, or stopped taking it altogether. The findings are important because obesity treatment often fails when people regain weight after their medication ends.
The trial found that people who kept taking tirzepatide at their regular dose successfully maintained their weight loss and the health benefits that came with it. These benefits included improvements in heart and metabolic health. The research also showed that dropping down to a lower dose of 5 mg could be a middle-ground option for some patients. However, the results weren't identical for everyone. Different people responded differently to dose changes, suggesting that treatment needs to be tailored to each individual.
These results highlight a key lesson about obesity treatment. Unlike short-term diets, managing obesity often requires ongoing medication. Stopping treatment tends to lead to weight regain and loss of the health improvements people gained. The study suggests that people shouldn't expect to take tirzepatide for a few months and then be done. Instead, staying on the medication long-term appears necessary to keep the weight off.
If you're considering tirzepatide or are already taking it, talk openly with your doctor about your treatment plan. Ask about how long you might need to stay on the medication and whether a lower dose could work for you. Weight management is personal, and your doctor can help you find the approach that fits your health goals and lifestyle. Don't assume that losing weight means you can stop treatment. The evidence shows that ongoing therapy gives you the best chance of keeping that weight off.
What you can doAI-generated
- ✓Talk to your doctor about whether tirzepatide is right for you before starting it, since this study shows you'll likely need to stay on it long-term to keep weight off.
- ✓Ask your prescriber about the 5 mg dose option if the standard dose causes side effects or costs too much, since the trial found it can work for some people as a maintenance strategy.
- ✓Read the label on your tirzepatide prescription and set a phone reminder to take it consistently, because stopping or skipping doses will likely trigger weight regain based on what this trial found.
- ✓Avoid thinking of tirzepatide as a temporary fix like a diet, and instead plan to discuss ongoing treatment as part of your long-term obesity management with your doctor.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
The LancetWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.